Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using <i>QuPath</i> digital image analysisMaurice B. Loughrey, Manuel Salto‐Tellez, Ronan T. Gray et al.|Histopathology|2018Cited by 85
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i> -mutant stage II and III colon cancerPhilip D. Dunne, Mark Lawler, Helen G. Coleman et al.|Oncotarget|2018Cited by 11
<i>Bcl-xL</i> as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in <i>BRAF</i> -mutant stage II and III colon cancerPhilip D. Dunne, Mark Lawler, Helen G. Coleman et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 1